Faeth Therapeutics files initial beneficial ownership statement for director Adam Schayowitz
FTH•Faeth Therapeutics director Adam Schayowitz signed his initial beneficial ownership statement on Oct. 27, 2026.
1. Ownership statement
Faeth Therapeutics director Adam Schayowitz’s initial statement of beneficial ownership was signed Oct. 27, 2026.
